Lessons from Hereditary Colorectal Cancer

  title={Lessons from Hereditary Colorectal Cancer},
  author={Kenneth W. Kinzler and Bert Vogelstein},

Figures and Tables from this paper

The APC I1307K allele and BRCA-associated ovarian cancer risk.

This work was supported by National Institutes of Health grant R01-CA71840. The authors are also grateful to Drs. William J. Hoskins and Patrick I. Borgen for their support of this laboratory.

Inherited carcinomas of the kidney.

Mosaicism and sporadic familial adenomatous polyposis.

This work acknowledges support from Cancer Research Campaign grant SP2326/0101, Scottish Health Department grant K/MRS/50/C2417, Scottish Hospitals Endowment Research Trust grant SHERT 1331 and a grant from Tenovus Scotland.

The molecular and genetic basis of colon cancer.

Broadsheet number 52: Molecular genetics of colorectal cancer.

It is shown how the fundamental principle of genetic instability cuts across applied research, tissue diagnosis and clinical management with respect to both sporadic and inherited forms of colorectal cancer.

Molecular genetics of colorectal cancer: An overview

Some of the common genetic pathways in CRC and the mechanisms of action for some of the key genes involved in the formation of CRC are described and may lead to the development of novel therapeutic approaches for treating this deadly disease.

Use of microsatellite analysis in young patients with colorectal cancer to identify those with hereditary nonpolyposis colorectal cancer

The frequency of microsatellite instability (MSI) in young patients with colorectal cancer was evaluated, including reexamination of the medical and family history of each patient, and interviews

Endoscopic management of familial colonic neoplasia.

Hereditary colorectal cancer.




Clues to the pathogenesis of familial colorectal cancer.

Molecular features of "familial" cancers were compared with those of sporadic colon cancers, and a mechanism for familial tumorigenesis different from that mediated by classic tumor suppressor genes is suggested.

Dominant genes for colorectal cancer are not rare

The genetic basis for colorectal cancer was investigated by complex segregation analysis of a published series of consecutive pedigrees ascertained through patients undergoing treatment for

Molecular determinants of dysplasia in colorectal lesions.

Analysis of small benign colorectal lesions for APC and K-RAS mutations provides evidence that the nature and order of genetic changes can have a specific impact on both tumor morphology and the likelihood of tumor progression.

Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives.

Independent investigators have identified four HNPCC genes: hMSH2 (a homologue of the prokaryotic DNA MMR gene MutS) and hMLH1, hPMS1, and hP MS2 (all homologues of the ProkARYotic DNAMMR gene MutL).

Antioncogenes and human cancer.

The identification of multiple genetic lesions is giving insight into the regulatory pathways in the cell and may translate into future improvements in prevention, diagnosis, prognosis, and therapy of human cancer.

Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.

Adenoma formation may include a stage in which multiple and genetically distinct neoplastic clones are present, while most carcinomas appear to have a homogeneous composition that may result from the successful progression of one of these clones.

Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). I. Clinical description of resource

One documented clinical feature was a predilection for proximal versus distal colonic cancer in both CFS and HSSCC kindreds, which clarifies the need for instituting effective surveillance earlier to detect the predominantly proximal colonic cancers.

Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.

The data suggest that more than one gene on chromosome 5q21 may contribute to colorectal neoplasia, and that mutations of the APC gene can cause both FAP and GS.

Clinical implications of the p53 tumor-suppressor gene.

The p53 tumor-suppressor gene is the most striking example because it is mutated in about half of almost all types of cancer arising from a wide spectrum of tissues.

K-ras mutations in putative preneoplastic lesions in human colon.

Mutation in K-ras is the earliest identified gene-mutational event in human colon tumorigenesis, establishes that it often occurs prior to the development of polyps, and is consistent with the hypothesis that aberrant crypt foci are the early identified precursors of human colon cancer.